Structure Info
- Chemspace ID
- CSSS07096521614 (In-Stock Screening Compounds)
- IUPAC Name
- 6-{3-[(4aR,7aS)-hexahydro-2H-[1,4]dioxino[2,3-c]pyrrol-6-yl]propoxy}-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine bis(methanesulfonic acid) hydrate
- Mol formula
- C26H36ClFN4O11S2
- Mol weight
- 699 Da
- Catalog Number(s)
- AA029R1L, AG029R4D, AR029RTD, BM14085, HY-153110A, T72207, Y3297129
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.65
- Heavy atoms count
- 45
- Rotatable bond count
- 8
- Number of rings
- 5
- Carbon bond saturation, Fsp3
- 0.461
- Polar surface area (Å)
- 78
- Hydrogen bond acceptors count
- 8
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSS07096521614
Items Overall 12 items from 2 suppliers
Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
---|---|---|---|---|---|---|
MedChemExpress | 10 days | United States To: | 99 | 5 mg | 245 | |
MedChemExpress | 10 days | United States To: | 99 | 10 mg | 380 | |
MedChemExpress | 10 days | United States To: | 99 | 25 mg | 800 | |
MedChemExpress | 10 days | United States To: | 99 | 50 mg | 1,280 | |
MedChemExpress | 10 days | United States To: | 99 | 100 mg | 2,100 | |
MedChemExpress | 10 days | United States To: | 99 | 10mM/1mL | 377 | |
Description: Names: Larotinib (mesylate hydrate); Product Description: Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC 50 of 0.6 nM .; Target: Btk;EGFR;IRAK; CAS: 2097129-93-4 | ||||||
MedChemExpress EU | 10 days | Sweden To: | 99 | 5 mg | 258 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10 mg | 401 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 25 mg | 843 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 50 mg | 1,348 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 100 mg | 2,212 | |
MedChemExpress EU | 10 days | Sweden To: | 99 | 10mM/1mL | 397 | |
Description: Names: Larotinib (mesylate hydrate); Product Description: Larotinib mesylate hydrate is a potent broad-spectrum and orally active tyrosine kinase inhibitor (TKI) with EGFR as the main target with an IC50 of 0.6 nM; Target: Btk;EGFR;IRAK; CAS: 2097129-93-4 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire